Immunocore Holdings plc
IMCR
$28.38
-$1.67-5.54%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.77M | 8.74M | -11.62M | -24.44M | -19.73M |
| Total Depreciation and Amortization | 1.17M | 1.04M | 992.00K | 1.01M | 1.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.90M | -6.66M | 6.87M | 10.70M | 21.68M |
| Change in Net Operating Assets | -8.25M | 18.01M | 27.22M | 8.14M | -20.71M |
| Cash from Operations | -13.95M | 21.13M | 23.47M | -4.59M | -17.73M |
| Capital Expenditure | -3.58M | -828.00K | -331.00K | -430.00K | -817.00K |
| Sale of Property, Plant, and Equipment | 44.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -350.00M | -- | -- |
| Cash from Investing | -3.54M | -828.00K | -350.33M | -430.00K | -817.00K |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 402.50M | -- |
| Total Debt Repaid | -52.06M | -- | -- | -- | -- |
| Issuance of Common Stock | 550.00K | 198.00K | 298.00K | 5.75M | 6.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -1.12M | -12.24M | -- |
| Cash from Financing | -51.51M | 198.00K | -818.00K | 396.01M | 6.25M |
| Foreign Exchange rate Adjustments | -13.03M | 12.29M | -159.00K | -800.00K | 10.78M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.04M | 32.78M | -327.84M | 390.20M | -1.51M |
